Table 3:
Summary of studies on TRT effect on HIV/AIDS
| Authors, Year | Country | Study Design | Number of Participants | Intervention | Outcome of Interest | Study Findings |
|---|---|---|---|---|---|---|
| Blick et al (2013) | USA | Prospective | 849 | Administration of 5 mg or 10 mg of 1% testosterone gel per day topically; in cohorts with and without HIV Duration: 12 months | Total testosterone, free testosterone levels, symptoms of depression, sexual function, body composition profiles, and prostate-specific antigen levels | Both men with and without HIV experienced elevations in total testosterone, and free testosterone levels to within normal ranges. For both cohorts, sexual function and depression scores improved and antidepressant medication use decreased. Body composition profiles improved significantly in men without HIV/AIDS and remained stable in men with HIV/AIDS during the 12 months of follow up. |
| Bhasin et al (2000) | USA | Prospective RCT | 61 | 100 mg testosterone enanthate/week intramuscularly with exercise Duration: 16 weeks | Changes in muscle strength, body weight, thigh muscle volume, and lean body mass | Testosterone and resistance exercise increased body weight, muscle mass, muscle strength, and lean body mass. Testosterone and exercise together did not produce greater gains than either intervention alone. |
| Grinspoon et al (2000) | USA | Prospective RCT | 54 | 200 mg testosterone enanthate/week or placebo and progressive resistance training 3 times/week or no training Duration: 12 weeks | Cross-sectional muscle area and other indices of muscle mass | Cross-sectional muscle area increased in response to training compared with non-training and in response to testosterone therapy compared with placebo. |
| Kong and Edmonds (2002) | USA | Review/meta-analysis | 417 | Review of randomized, placebo-controlled trails that compared the effects of TRT vs. placebo | Lean body mass, total body weight, overall exercise functional capacity, and perceived quality of life | The meta-analysis of the six trials showed a difference in the lean body mass between the testosterone group and placebo group of 1.22 kg in the random effect model, 0.51 kg in the fixed effect model, and 3.34 kg for trials that used the intramuscular route. |
RCT = Randomized Control Trial